Inventurus Knowledge Solutions IPO

Inventurus Knowledge Solutions IPO Details

Inventurus Knowledge Solutions IPO Date

The Inventurus Knowledge Solutions Limited IPO will open for subscription on December 12, 2024, and the closing date for the IPO is December 16, 2024, according to the offer document filed by the company with the SEBI. After this, investors are expected to be updated about the allotment status on Tuesday, December 17, 2024.

Investors who have been allotted shares can expect them to be credited to their demat account on December 18, 2024. The shares will be listed on the NSE and the BSE on Thursday, December 19, 2024.

Inventurus Knowledge Solutions IPO Price Band

The IPO issues an offer-for-sale (OFS) component. The IPO price band has been set between ₹1,265 to ₹1,329 per share. Interested investors can choose a price within this band to apply for the IPO.

The IPO is a book-building issue of ₹2,497.92 crore, with an offer for sale of 1.87 crore shares (totalling ₹2,497.92 crore).

The Inventurus Knowledge Solutions Limited IPO listing price will be determined on December 19, 2024. The listing price is the price at which a company’s shares debut on the stock exchanges. 

Inventurus Knowledge Solutions IPO Lot Size

The Inventurus Knowledge Solutions Limited IPO details have been declared. The minimum lot size for an application is 11 shares, and the investor would have to apply for a minimum of 1 lot. Meanwhile, the IPO issue size is approximately ₹2,497.92 crore.

Inventurus Knowledge Solutions IPO Objective

The entire proceeds from the issue will be received by the selling shareholders, after deducting the offer expenses and relevant taxes. The objective of the offer is to achieve the benefits of listing shares on the bourses and carry out the offer-for-sale for the promoter-selling shareholders.

About Inventurus Knowledge Solutions

Inventurus Knowledge Solutions Limited (IKS Health), founded in 2006, is a technology-driven healthcare solutions provider specialising in streamlining administrative tasks for healthcare enterprises. The company supports both outpatient and inpatient care organisations, primarily in the United States, with additional operations in Canada and Australia.

IKS Health’s outpatient services cover a range of non-admission care, including observation, consultation, diagnosis, and treatment. Inpatient services focus on providing medical treatment for patients requiring extended stays at healthcare facilities. 

As of September 30, 2024, IKS Health serves over 778 US-based healthcare organisations, including renowned clients such as Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management.

IKS Health’s proprietary technology solutions are central to its success, offering innovative tools that streamline healthcare operations. Their advanced platform integrates clinical support, medical documentation management, and virtual medical scribing, enabling healthcare providers to reduce administrative burdens and improve efficiency. By leveraging these cutting-edge technologies, IKS Health helps organisations enhance patient care and optimise both operational and financial outcomes.

Between FY22 and FY24, its revenue from operations rose at a CAGR of over 33.54%. Moreover, health expenditures in the US are expected to grow at a CAGR of 5.3% to reach $6,216 billion by 2028. Out of this, the total addressable market for provider enablement technology solutions in the US is expected to reach $323 billion by 2028, which indicates steady industry growth. This massive market size indirectly offers the company a huge opportunity to expand its business.  

Now, Inventurus Knowledge Solutions Limited is launching its initial public offer (IPO). The total IPO issue size is ₹2,497.92 crore, which is entirely offer for sale (OFS). Its shares will be listed on the NSE and BSE.

Company Name:   Inventurus Knowledge Solutions Limited

Company Established On: September 5, 2006

Company Type: Private Limited Company

Financial snapshot

Inventurus Knowledge Solutions IPO Analysis

Strengths and Opportunities

1. IKS Health’s advanced solutions, including IKS EVE and Optimix, optimise patient access, engagement, and revenue by streamlining insurance verification, billing, and claims management.
2. The use of advanced technologies like generative AI, OCR, and NLP across platforms improves clinical documentation, prescription renewals, and claims management.
3. In October 2023, the company completed the acquisition of Aquity Holdings, a company engaged in technology-enabled clinical documentation, medical coding, and revenue integrity solutions for healthcare.
4. Through this acquisition, IKS Health can cross-sell its services to Aquity Holdings' existing base of over 804 clients, thereby increasing our market opportunity. 
5. IKS Health’s "tech-led human-enabled" model ensures non-linear scalability, boosting revenue potential without a proportional rise in operational costs.
6. Collaborations with organisations like Mass General Brigham refine solutions to ensure clinical safety and operational feasibility and address industry challenges.
7. IKS Health supports the shift to value-based care with tailored solutions.

Risks and Threats

1. The company has faced FEMA-related compliance deficiencies, which could result in regulatory actions and penalties. It has pending compounding applications to the RBI.
2. Ongoing litigation poses potential risks to the company’s reputation and operational performance, with an adverse outcome possibly impacting its business.
3. The company's reliance on artificial intelligence and machine learning technologies requires successful development and integration to maintain its revenue and reputation.
4. Healthcare regulations and government restrictions on pricing and reimbursement could adversely affect the company’s business and operations.
5. The company is exposed to risks related to client churn, reliance on third-party vendors, and the potential impact of market fluctuations on its financial performance. 

How to apply for the Inventurus Knowledge Solutions IPO?

If you are interested to invest in Inventurus Knowledge Solutions IPO, following are the steps to apply:

1. Login to your Upstox account, using your six-digit PIN
2. After successfully logging in, click on ‘Discover’
3. On the Discover tab, you will find the ‘Invest in IPO’ section
4. Under the Invest in IPO section, look for the ‘Inventurus Knowledge Solutions IPO’ tab and click on it
5. Now fill in all the required information, like ‘bid price’ and ‘lot size’
6. Confirm and click on ‘Apply’
7. Accept the mandate on your UPI app

You can also pre-apply for the Inventurus Knowledge Solutions IPO on Upstox which usually begins a day before the IPO opens for subscription.